Skip to content
10-Q/A

Quarterly Report

ANTIVIRAL TECHNOLOGIES, INC.

0001137050-14-000100

← back to feed
Filed
May 19, 2014 12:00 AM ET
Period of report
Amendment. Amends a previously filed report.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2014 · Mar 31, 2014 150M sh
Operating Cash Flow Q1 2014 · Mar 31, 2014 −$19.25K
Operating Cash Flow Q1 2014 · Mar 31, 2014 −$1.31M
Operating Cash Flow Q1 2014 · Mar 31, 2013 −$11.21K
Cash And Equivalents Q1 2014 · Mar 31, 2014 $399
Cash And Equivalents Q1 2014 · Dec 31, 2013 $499
Cash And Equivalents Q1 2014 · Dec 31, 2012 $699
Stockholders Equity Q1 2014 · Mar 31, 2014 −$2.76M
Stockholders Equity Q1 2014 · Dec 31, 2013 −$2.68M
Total Liabilities Q1 2014 · Mar 31, 2014 $3.25M
Total Liabilities Q1 2014 · Dec 31, 2013 $3.17M
Current Assets Q1 2014 · Mar 31, 2014 $401
Current Assets Q1 2014 · Dec 31, 2013 $501
Total Assets Q1 2014 · Mar 31, 2014 $489.44K
Total Assets Q1 2014 · Dec 31, 2013 $484.16K
Sga Expense Q1 2014 · Mar 31, 2014 $76.68K
Sga Expense Q1 2014 · Mar 31, 2014 $2.58M
Sga Expense Q1 2014 · Mar 31, 2013 $84.83K
Net Income Q1 2014 · Mar 31, 2014 −$76.68K
Net Income Q1 2014 · Mar 31, 2014 −$2.75M
Net Income Q1 2014 · Mar 31, 2013 −$84.92K